The importance of the research and clinical care work at Joslin Diabetes Center in Boston has been affirmed by a report from the Centers for Disease Control and Prevention predicting that one-third of all U.S. adults will have diabetes by 2050 if current trends continue.
“The Center is unique in its exclusive focus on ensuring that people with diabetes live long, healthy lives. Joslin offers real hope and progress toward diabetes prevention and a cure.”
Joslin Diabetes Center, the world's preeminent diabetes research and clinical care organization, dedicates a team of over 600 people and $40 million annually to research and innovations in clinical care focusing on type 1 and type 2 diabetes and related complications. According to Michael P. Sullivan, Sr. Vice President at Joslin, "The Center is unique in its exclusive focus on ensuring that people with diabetes live long, healthy lives. Joslin offers real hope and progress toward diabetes prevention and a cure."
Sullivan points out that as an independent 501(c)(3), the Joslin Diabetes Center depends on the generosity of donors to support its mission, and that public can support Joslin by participating in two exciting fundraisers to benefit the Center's High Hopes Fund, which supports Joslin's efforts to improve the lives of people with diabetes through care, education and research, and to prevent and cure the disease.
Supporters can purchase tickets for the Iacocca Mustang Raffle to win a rare 45th Anniversary Edition Iacocca Mustang, one of only 45 in the world. Joslin fans are also invited to participate in Ray's 3 for 3's by committing a $3 donation to Joslin for each 3-point shot Boston Celtics star Ray Allen makes during the 2010-2011 season. Two years ago, Ray Allen's young son, Walker, was diagnosed with type 1 diabetes and has received treatment at the Joslin Diabetes Center.
Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options